Table 1.
Cancers with strong link to obesity
| Men | ||
|
| ||
| RR (95% CI) | p | |
|
| ||
| Esophageal Adenocarcinoma | 1.52 (1.33-1.74) | <0.0001 |
| Thyroid | 1.33 (1.04-1.70) | 0.02 |
| Colon | 1.24 (1.20-1.28) | <0.0001 |
| Renal | 1.24 (1.15-1.34) | <0.0001 |
| Malignant melanoma | 1.17 (1.05-1.30) | 0.004 |
| Multiple myeloma | 1.11 (1.05-1.18) | <0.0001 |
| Rectum | 1.09 (0.99-1.21) | <0.0001 |
|
| ||
| Women | ||
|
| ||
| RR (95% CI) | p value | |
|
| ||
| Endometrial | 1.59 (1.50-1.68) | <0.0001 |
| Gallbladder | 1.59 (1.02-2.47) | 0.04 |
| Esophageal | 1.51 (1.31-1.74) | <0.0001 |
| Renal | 1.34 (1.25-1.43) | <0.0001 |
| Leukemia | 1.17 (1.04-1.32) | 0.01 |
| Thyroid | 1.14(1.06-1.23) | 0.001 |
| Breast | 1.12 (1.08-1.16) | <0.0001 |
Adapted from Renehan et al [12], “Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies” 2008. Lancet 371: 569-578.